- NSA has been tracking Trump for years. Evidence for

New Post Public Reply Private Reply Replies (1) Message Board
Bhawks Lmcat #57409
100
- NSA has been tracking Trump for years.

Evidence for that claim?


Quote:
The United States and Russia aren’t allies. But Trump and Putin are.
Robert


KaganTuesday, July 24, 2018


Presidents Trump and Putin have a common view of the liberal world order that the United States helped create seven decades ago. Both leaders seek its destruction, writes Robert Kagan. This piece was originally published by NPR on July 17.




Because it is hard to break old patterns of understanding the world, we have persistently misunderstood Donald Trump and what he is up to. Thus most observers of the Helsinki summit—critics and defenders alike—expected to see some version of the traditional meeting between American and Russian leaders: two adversaries coming together to address mutual concerns, raise objections, talk over possible solutions and seek common ground.

There was the standard list of issues—Syria, Ukraine, nuclear weapons—on which to make progress or not. There were the standard concerns: Would Trump give up too much, out of naiveté, or for other, more nefarious reasons?

And there were the standard justifications: What’s wrong with adversaries getting together to discuss their differences? Why not seek ways to lower tensions?

What observers could not see, or refused to see, was that this was not a meeting between adversaries. It was a meeting between allies, with convergent interests and common goals.

These, incidentally, have nothing to do with the 2016 election. They have to do with a common view of the liberal world order that the United States helped create seven decades ago. Both leaders seek its destruction.

Putin’s interests come as no surprise. He has regarded the U.S.-led liberal world order as Russia’s greatest adversary his whole life. It contained and then undermined the Soviet Union—the breakup of which was the “greatest tragedy of the 20th century,” as he once put it—and then deprived post-Soviet Russia of its sphere of influence in eastern and central Europe.

The triumph of the liberal world order after 1989 left Russia a second-tier power with a weak economy and embarrassingly diminished international clout. Putin has therefore sought, just as other Russian leaders have in the past, to weaken, divide and demoralize the liberal world. He has supported right-wing nationalist parties throughout Europe. He has tried to weaken and undermine the European Union and NATO. And it is understandable why.

When the West is strong and coherent, Russia has little room to maneuver. Only when the West is in disarray—as it was during the Napoleonic Wars, for instance, or during the 1930s and 1940s—can Russia be a major global power and fulfill dreams of empire going back to Peter the Great. Only then can Russian leaders like Putin deliver geopolitical victories to distract attention from domestic failures.

Putin never had an interest in integrating Russia into the liberal world order, therefore, even though the average Russian would have benefited, at least materially. He depends on confrontation and chaos.

And, as it happens, so does Trump.
That has certainly been his strength in domestic politics, and he has transferred his domestic modus operandi to the world stage.

His success at home came from stirring up populist, nationalist passions against what he and his supporters regarded as an entrenched cosmopolitan elite. It’s hardly surprising that he would view the world through the same lens, that he would support populist, nationalist movements across Europe against the traditional parties that have upheld the liberal world order.

It is not just the European Union that he regards as a hostile foe—it is all the institutions and arrangements of the liberal world to which past American presidents of both parties have paid their allegiance.


He regards them both as constraints on his freedom of action and as inherently hostile to him and his followers—which they are.

Therefore, he seeks to destroy them, as he made clear not only at the NATO summit but throughout his presidency.


Like Putin, he has thrown his support to Hungary’s Viktor Orban, as well as to the right nationalist parties of France, Italy, the United Kingdom, and across Europe. Like Putin, he supported Brexit and sees it as a way of breaking the EU.

Like Putin, he hates Angela Merkel and would prefer the triumph of right-wing parties in Germany.

Many asked before the summit what Putin would ask of Trump. Afterward, they breathed a sigh of relief that Trump did not give anything away. And the two men actually worked hard to make this look like the kind of summit people were used to, a typical meeting of adversaries trying to work out their differences and not entirely succeeding.

Few noticed, but it was rather odd for Putin to declare publicly that he and Trump did not agree about Crimea, especially when we know from some of Trump’s own statements prior to the summit that they fundamentally do agree.

Putin was putting on a show of great power disagreement, reassuring Trump’s critics and defenders that the president was indeed standing up to him on some issues. And sure enough, even critics were quick to say that Trump, on substance, had given no ground. (Little could Putin imagine that Trump would then crumb the play by publicly siding with him on the question of election interference.)

What they apparently failed to notice was that Trump had already given everything away. In Putin’s eyes, Syria and Crimea are trivialities compared with the collapse of the liberal West.

At the summit, Putin acknowledged that he wanted to see Trump elected in 2016. While Western commentators persist in believing he must be disappointed, the payoff has probably exceeded his wildest dreams.


Scroll down for more posts ▼

Top 10 Most Recent News Articles

Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 233

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 155

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 351

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 122

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
IEHP's Wellness Center Launch Faces Delay in California

Updated Category News Views 115

Unexpected Delay for IEHP's Community Hub Straight outta Rancho Cucamonga, we've got some news that'll have folks in San Bernardino holding their breath a little longer. The Inland Empire Health Plan (or IEHP if you're part of the 1.4 million served by them) had folks pumped for their new Community Wellness Center. But guess what? They had to slam the brakes on the grand...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Beko Pushes for Policy Synergy Amidst Carbon Shakeup

Updated Category News Views 166

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 166

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 116

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading

Top 5 Most Recently Viewed Articles

R Systems Shines as a Major Contender in Engineering Services

Updated Category News Views 206

R Systems Acknowledged for Engineering Excellence R Systems International Limited, a leader in digital product engineering and technology solutions, has been recognized in the latest evaluation conducted by Everest Group. This prominent acknowledgment positions R Systems as a Major Contender in the ISV and Internet-specific SPES PEAK Matrix® Assessment for the year 2024....

Continue Reading
AppFolio Achieves Growth: Analysts Reaffirm $300 Target

Updated Category News Views 68

DA Davidson Affirms $300 Price Target for AppFolio Recently, DA Davidson reaffirmed its Buy rating for AppFolio (NASDAQ: APPF) and maintained a price target of $300. As a leading provider of cloud-based software solutions, AppFolio is recognized for its strategic growth initiatives. The firm highlighted the company's momentum ahead of its third-quarter earnings report and...

Continue Reading
Important Class Action Emerging for West Pharmaceutical Services Investors

Updated Category News Views 162

Class Action Overview for West Pharmaceutical Services, Inc. Levi & Korsinsky, LLP informs all investors in West Pharmaceutical Services, Inc. about a significant class action securities lawsuit arising from claims of securities fraud against the company. This announcement serves as an important notice to those who hold shares of West Pharmaceutical Services, Inc. (NYSE:...

Continue Reading
Zelluna's Upcoming Forum: Insight into Cancer Treatment Strategies

Updated Category News Views 190

Explore the Upcoming Investor Forum by Zelluna Zelluna (OSE: ZLNA), a trailblazer in the realm of allogeneic 'off the shelf' T Cell Receptor-based Natural Killer (TCR-NK) cells aimed at combating cancer, has announced an engaging Investor Science and Strategy Forum that offers a closer look at their innovative approaches. This notable event is set to take place in Oslo,...

Continue Reading
Challenges Facing Airlines Due to Economic Shifts and Strikes

Updated Category News Views 296

Understanding the Shift in Airline Operations As airlines adapt to changing economic conditions and demand patterns, many have begun scaling back their flight offerings to certain international markets. The situation is particularly pronounced with regards to flights to China, where reduced demand and rising operational costs have forced several airlines to reconsider...

Continue Reading